The following books were recommended for reading to oncologists by the editors of an oncology journal, Cancer Network. Happy reading!
Congress highlights need for National Cancer Institute to increase attention to kidney cancer research and its early detection efforts. Yesterday (December 18, 2015), Congress passed the $1.8 trillion omnibus appropriation bill for Fiscal Year 2016 (October 1, 2015 – September 30, 2016). The bill calls for an increase of $2 billion in the NIH budged and $264 million in the National Cancer Institute’s budget, bringing the latter to $5.2 billion. This is good news considering… More →
Hans Hammers from Johns Hopkins Cancer Center won an Idea Award from the Department of Defense for Fiscal Year 2014 for “Enhancing Immune Checkpoint Inhibitor Therapy in Kidney Cancer”. This is a two-year grant in the amount of $486,000 awarded to Dr. Hammers and Johns Hopkins. DoD grants have normally gone to pure researchers, but Dr. Hammers, aside from doing research, is also an eminent clinical oncologist who has made a number of presentations… More →
Exelixis Announces Start of Phase 1 Trial of Cabozantinib in Combination with Nivolumab or Nivolumab Plus Ipilimumab in Patients with Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors SOUTH SAN FRANCISCO, Calif. — (BUSINESS WIRE) — Jul. 13, 2015 — Exelixis, Inc. (NASDAQ:EXEL) today announced the initiation of a phase 1 trial of cabozantinib in combination with nivolumab alone or in combination with nivolumab plus ipilimumab in patients with advanced/metastatic urothelial (bladder) and other genitourinary tumors…. More →
Dr. W. Marston Linehan, Chief of Urologic Oncology at the National Cancer Institute (NCI) recently spoke to the advocacy group that gathered in Washington, DC, for ACKC’s annual Campaign for Research Funding. Dr. Linehan spoke to the group in layman’s terms regarding the recent advances in kidney cancer research (see video below). He described the strong sense of hope and excitement for major breakthroughs that may be coming as researchers are making significant progress regarding… More →